Marijuana Stocks & Plays

[Golden Cross]

$PAOG PAO Group Proudly Announces New MJ Entity Acquisition

SANDUSKY, OH -- January 10, 2019 -- InvestorsHub NewsWire -- PAO Group, Inc. (PAOG), a physicians practice management company, focused on the proper use of cannabis for treatment of chronic pain, opioid addictions, and terminal patients, is pleased to announce that it has completed the process of transferring all existing corporate assets to Rising Biosciences, Inc. (RBII).

Simultaneous with the transfer of all old assets to Rising Biosciences, PAO Group has acquired RSB Management Inc., a business management company in the cannabis sector. The definitive acquisition agreement between PAO Group and RSB Management has been executed by all necessary parties and the Company is proud to report that the acquisition was closed on December 31st, 2018.

PAOG is now in the process of posting its financial statements with OTC Markets in order to achieve current status. Upon completion of this process interim CEO Arthur Hall will be stepping down and new management changes will take effect.

Outgoing PAOG Interim CEO Arthur Hall stated: "This new acquisition will become the new PAOG. The outgoing executive team is fulfilling our stated commitment to shareholders by adding an entity of immense value that is in line with PAOG's historic philosophy, mission, and industry sector. I am very proud to hand the baton to the experienced and successful leadership of RSB Management and believe that there will be future synergies between the incoming company and Rising Biosciences, Inc. It is now my pleasure to introduce our valued investors to the superstar team that is RSB Management."

Incoming PAOG CEO Karl Riedel was employed most recently as Executive Vice President of Marketing for VMR Products LLC, the largest online vendor of electronic cigarettes and vapor devices. He was with the company for 8+ years and helped carry VMR through a recent acquisition by JUUL Labs, Inc. for $75M (https://vaping360.com/vape-news/72683/why-did-juul-buy-v2-and-vmr-products/). As Executive VP, he was responsible for overseeing online marketing initiatives, E-Commerce sales & promotions, Merchandising both domestically and internationally, Press and Media relations, Search Engine Optimization (SEO), Social Media influencers and engagement, and Affiliate Marketing initiatives. He built the largest affiliate program in the vapor industry the V2 Profit Affiliate Network with 9000+ affiliates worldwide generating traffic and sales to VMR's e-commerce websites.

With 14+ years experience across a diverse array of technical fields including Content Management, IT and software implementation, and Affiliate Marketing, Karl leveraged a diverse, multi-platform marketing strategy across VMR's brands. He has held a variety of positions in the new media and technology industries; most recently management positions in two of the portfolio companies of Verleur Capital Ventures, LLC. Karl possesses a Bachelors of Arts from Miami University (Oxford, OH) where he graduated with Honors in Psychology, and he attended law school at University of Miami (FL).

Karl has been interviewed by magazines like Forbes and the MJ Business Journal. The articles below represent an assortment of places where Karl has been quoted while serving as Executive VP for VMR:

https://www.inverse.com/article/36937-prohibited-in-the-5th-degree-review-dry-herb-vaporizer
https://mjbizmagazine.com/digital-issues/2018-02-Feb/64/
http://www.b2bwholesalermag.com/vmrproducts.html#
http://erbmagazine.com/vendor-spotlight-vol-63/

Incoming CFO Tom Sawyer boasts not only an Accounting Degree from Henry Ford College, but he is also a Master Grower who has been a member of the Michigan medical marihuana* program since its inception (circa 2008). With 10+ years in the cannabis industry, he is well-versed in standard business practices within the state of Michigan. Tom previously worked at an accounting firm under a financial advisor with a $27M portfolio, and he managed payroll and bookkeeping for approximately 30 companies and 100+ employees. Tom's diverse and unique mix of skills give PAO Group an added advantage by having an accounting professional with real world cannabis experience to manage the daily operations of cultivation and processing. His background in both financial and managerial accounting ensures shareholders are provided with up-to-date and accurate business metrics data at all times.

Incoming COO Patrick Blasko is a proven Entrepreneur versed in both business management and start-up experience, with 12+ years' experience in B2C retail. Patrick's vast knowledge pertaining to the wholesale and retail side of the industry allowed him to grow and expand his current business to multiple brick-and-mortar locations. Understanding profit and growth challenges along with inventory management skills, Patrick will be the key component to establishing and growing vendor relations. He has forged solid business relationships with distributors, shops and dispensaries which gives PAOG a serious advantage with sourced product, particularly during periods of rapid growth or business transformation when execution risks are high.

Incoming PAOG CEO Karl Riedel enthusiastically commented: "After my experience with VMR, I decided that I wanted to do something bigger. I am passionate about the cannabis industry and am confident that we can build a powerhouse brand in the Michigan market through a coordinated effort of delivering high quality products, combined with effective branding and targeted marketing. We have assembled a team of dedicated, hard-working, and skilled professionals with a unique array of talents to drive these initiatives. With the recent legalization of recreational marijuana, and transition to licensed-only grow operations and processing facilities within the state, the market is prime for entry. We already have the infrastructure and relationships in place to be strategically positioned in the Michigan cannabis market. My goal for PAOG is to be the dominant player in Michigan regarding the cultivation, processing, and transportation of medical and recreational marijuana. We are hitting the ground running in 2019. I'm very excited to begin telling investors about our plans to achieve these objectives.

My long term vision for PAOG is to continue to drive this business growth, as well as focus on expansion to other markets."

[Golden Cross]

$PAOG Getting two golden crosses for one with #PAOG

[Golden Cross]

$PAOG MACD is creeping up towards a golden cross along with the 50/200dma. Two at one time if we see the 01+ this week as I expect to see.

[Golden Cross]

$PAOG PAO Group Proudly Announces New MJ Entity Acquisition

SANDUSKY, OH -- January 10, 2019 -- InvestorsHub NewsWire -- PAO Group, Inc. (PAOG), a physicians practice management company, focused on the proper use of cannabis for treatment of chronic pain, opioid addictions, and terminal patients, is pleased to announce that it has completed the process of transferring all existing corporate assets to Rising Biosciences, Inc. (RBII).

Simultaneous with the transfer of all old assets to Rising Biosciences, PAO Group has acquired RSB Management Inc., a business management company in the cannabis sector. The definitive acquisition agreement between PAO Group and RSB Management has been executed by all necessary parties and the Company is proud to report that the acquisition was closed on December 31st, 2018.

PAOG is now in the process of posting its financial statements with OTC Markets in order to achieve current status. Upon completion of this process interim CEO Arthur Hall will be stepping down and new management changes will take effect.

Outgoing PAOG Interim CEO Arthur Hall stated: "This new acquisition will become the new PAOG. The outgoing executive team is fulfilling our stated commitment to shareholders by adding an entity of immense value that is in line with PAOG's historic philosophy, mission, and industry sector. I am very proud to hand the baton to the experienced and successful leadership of RSB Management and believe that there will be future synergies between the incoming company and Rising Biosciences, Inc. It is now my pleasure to introduce our valued investors to the superstar team that is RSB Management."

Incoming PAOG CEO Karl Riedel was employed most recently as Executive Vice President of Marketing for VMR Products LLC, the largest online vendor of electronic cigarettes and vapor devices. He was with the company for 8+ years and helped carry VMR through a recent acquisition by JUUL Labs, Inc. for $75M (https://vaping360.com/vape-news/72683/why-did-juul-buy-v2-and-vmr-products/). As Executive VP, he was responsible for overseeing online marketing initiatives, E-Commerce sales & promotions, Merchandising both domestically and internationally, Press and Media relations, Search Engine Optimization (SEO), Social Media influencers and engagement, and Affiliate Marketing initiatives. He built the largest affiliate program in the vapor industry the V2 Profit Affiliate Network with 9000+ affiliates worldwide generating traffic and sales to VMR's e-commerce websites.

With 14+ years experience across a diverse array of technical fields including Content Management, IT and software implementation, and Affiliate Marketing, Karl leveraged a diverse, multi-platform marketing strategy across VMR's brands. He has held a variety of positions in the new media and technology industries; most recently management positions in two of the portfolio companies of Verleur Capital Ventures, LLC. Karl possesses a Bachelors of Arts from Miami University (Oxford, OH) where he graduated with Honors in Psychology, and he attended law school at University of Miami (FL).

Karl has been interviewed by magazines like Forbes and the MJ Business Journal. The articles below represent an assortment of places where Karl has been quoted while serving as Executive VP for VMR:

https://www.inverse.com/article/36937-prohibited-in-the-5th-degree-review-dry-herb-vaporizer
https://mjbizmagazine.com/digital-issues/2018-02-Feb/64/
http://www.b2bwholesalermag.com/vmrproducts.html#
http://erbmagazine.com/vendor-spotlight-vol-63/

Incoming CFO Tom Sawyer boasts not only an Accounting Degree from Henry Ford College, but he is also a Master Grower who has been a member of the Michigan medical marihuana* program since its inception (circa 2008). With 10+ years in the cannabis industry, he is well-versed in standard business practices within the state of Michigan. Tom previously worked at an accounting firm under a financial advisor with a $27M portfolio, and he managed payroll and bookkeeping for approximately 30 companies and 100+ employees. Tom's diverse and unique mix of skills give PAO Group an added advantage by having an accounting professional with real world cannabis experience to manage the daily operations of cultivation and processing. His background in both financial and managerial accounting ensures shareholders are provided with up-to-date and accurate business metrics data at all times.

Incoming COO Patrick Blasko is a proven Entrepreneur versed in both business management and start-up experience, with 12+ years' experience in B2C retail. Patrick's vast knowledge pertaining to the wholesale and retail side of the industry allowed him to grow and expand his current business to multiple brick-and-mortar locations. Understanding profit and growth challenges along with inventory management skills, Patrick will be the key component to establishing and growing vendor relations. He has forged solid business relationships with distributors, shops and dispensaries which gives PAOG a serious advantage with sourced product, particularly during periods of rapid growth or business transformation when execution risks are high.

Incoming PAOG CEO Karl Riedel enthusiastically commented: "After my experience with VMR, I decided that I wanted to do something bigger. I am passionate about the cannabis industry and am confident that we can build a powerhouse brand in the Michigan market through a coordinated effort of delivering high quality products, combined with effective branding and targeted marketing. We have assembled a team of dedicated, hard-working, and skilled professionals with a unique array of talents to drive these initiatives. With the recent legalization of recreational marijuana, and transition to licensed-only grow operations and processing facilities within the state, the market is prime for entry. We already have the infrastructure and relationships in place to be strategically positioned in the Michigan cannabis market. My goal for PAOG is to be the dominant player in Michigan regarding the cultivation, processing, and transportation of medical and recreational marijuana. We are hitting the ground running in 2019. I'm very excited to begin telling investors about our plans to achieve these objectives.

My long term vision for PAOG is to continue to drive this business growth, as well as focus on expansion to other markets."

[jedijazz]

$EPAZ Epazz is addressing a rising demand in the legal cannabis industry through its ZenaPay payment system designed Cannabis sector. Payment demo video on Vimeo: https://vimeo.com/216509479

[Golden Cross]

$CRON run continuing after MACD golden cross... ready to break out here

[Golden Cross]

$OCSY Optium Cyber Systems Enters Negotiations to Acquire Organic Cannabidiol Company GlobeNewswire "Press Releases"
THE WOODLANDS, TEXAS , Nov. 29, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- OptiumCyber Systems, Inc. (OTC:OCSY) would like to inform shareholders that it has commenced negotiations to acquire an organic cannabidiol development and marketing company. The target company (the Acquisition) has a complete product line which is generating sales and poised for significant growth. The proposed Acquisition would operate independently as a wholly owned subsidiary of Optium Cyber Systems.

This new opportunity came by way of a former director and officer of Optium Cyber Systems, stated George Rutherford , President of Optium Cyber Systems, Inc. We feel strongly that it is worth pursuing as the Acquisitions product line is in the market place and gaining traction. There are also a number of very exciting products under development. This is a turn-key situation with existing products, revenue, and infrastructureand will operate independently as a wholly owned subsidiary. We see this as a great opportunity to add shareholder value, concluded Mr. Rutherford .
About Optium Cyber Systems, Inc.
Optium Cyber Systems, Inc. (Optium) is a cyber security consulting company that has developed a process to analyze, identify and address cyber security vulnerabilities in an organizations critical IT infrastructure which is scalable to any size organization in any industry. Optium Cyber Systems, Inc. recently entered into an agreement to acquire 100% of the outstanding ownership interest of Iron Man Protection, LLC . Optium Cyber Systems, Inc. is a publicly traded company having its common shares quoted on the OTC Markets under the symbol OCSY.
Contact Information
Investor Relations
Ten Associates LLC
11529 N. 120th St.
Scottsdale, Arizona
85259 USA
Telephone: [phone]
Contact: Thomas E. Nelson
Email: [e-mail]
Optium Cyber Systems, Inc.
8350 Ashlane Way , Suite 104
The Woodlands, Texas
77382 USA
Contact: George Rutherford
Telephone: [phone]
Email: [e-mail]
Web:www.optiumcyber.com

[Golden Cross]

$HYDDF Molson Coors makes cannabis-infused beverage deal in Canada

Ben Miller
Published 2:44 PM ET Wed, 1 Aug 2018
Denver Business Journal

Molson Coors Brewing Co. said its Canadian unit is entering into a deal that will develop cannabis-infused beverages in Canada.

The Denver brewer said its Canadian unit, Molson Coors Canada, is teaming with Canadian cannabis producer, The Hydropothecary Corporation (HEXO), to create a joint partnership "to pursue opportunities to develop non-alcoholic, cannabis-infused beverages for the Canadian market following legalization." Marijuana use in Canada will become legal later this year.

"Canada is breaking new ground in the cannabis sector and, as one of the country's leading beverage companies, Molson Coors Canada has a unique opportunity to participate in this exciting and rapidly expanding consumer segment," said Frederic Landtmeters, president and CEO of Molson Coors Canada, in a statement.

Molson Coors Canada will have a 57.5 percent controlling interest in the joint standalone venture and HEXO will control the remainder.

[Golden Cross]

FARM BILL AGREEMENT on Track FOR Next Week

[Golden Cross]

$ADVT Look for a dip and rip opportunity here. Great day yesterday. Lots of new eyes will be on ADVT on run past 09+

[Golden Cross]

$CRON Cronos Group Price Target Raised to C$9.00/Share From C$7.50 by Canaccord Genuity

[Golden Cross]

$ACB Acquisitions Fueling #ACB Growth

[StockHighAlert-]

$MFST is pleased to announce a company update.

[BottomBounce]

$TRTC Cannabis CBD Oil and Medical Marijuana

[BottomBounce]

$INSY Holy Grail

[BottomBounce]

$HEMP Hemp, Inc. is a publically traded company (OTC: HEMP) that was founded in 2008. The company's long-term goal is to be the leader in the industrial hemp industry in America, which is now estimated to be over $500 Million. Hemp, Inc.'s mission is to provide green solutions that help make the world a better place to live. We support products that are eco friendly, organic, healthy, and solutions that replace many petroleum-based products. In a forward thinking move, Hemp, Inc.'s wholly owned subsidiary Industrial Hemp Manufacturing, LLC purchased the largest decortication plant in North America, which is located in Spring Hope, North Carolina. The plant is housed in a 70,000 square foot warehouse on 9 acres and is scheduled for completion in the last quarter of 2015. The company will start producing fiber, loss circulation materials (LCM) and absorbents from kenaf and later from hemp. Initially, Hemp, Inc. will produce a product for drilling rigs called "lost circulation material" (LCM), which is used for maintaining the seals when drilling for water, oil, gas, and any other liquid or gas. This product alone is capable of producing millions of dollars in revenue, since some of the largest oil companies in the world will be our primary customers. Eventually, the company will produce fiber materials for the paper and fabric industries, and other industries that utilize materials from hemp to make products such as plastics, building materials, health and beauty related products and more. Hemp, Inc. plans to purchase, acquire and/or joint venture with complimentary companies across various sectors of the hemp industry in an effort to build a portfolio of synergistic businesses that will bring Hemp, Inc. cash flow, revenues, value, and position us as a leader in the industrial hemp industry. https://www.otcmarkets.com/stock/HEMP/profile

[MarijuanaStockMillionaire]

TRGCF/TCI and GEATF/JUJU, Bob Marley, Willie Nelson

[StockDetective]

$PAOG PAO Group, Inc., is a physicians practice management company actively developing alternative medicine clinics focused on the proper use of cannabis for treatment of chronic and terminal patients.

Our success comes from providing patients with safe and confidential access to quality alternative healthcare, while providing them with the most professional support systems they come to expect. Alternative medicine centers of America provides the community and patient with the most current, innovative and dynamic wellness information and services possible. Alternative medicine centers of America brings to light each individual’s personal wellness potential, and facilitates their journey to harmonious fitness.

https://www.pao.group/

More alternative medicine clinics coming soon!!

https://altmedcenters.com/locations-florida/

https://altmedcenters.com/locations-ohio/

MJ sector about to heat up...

https://www.ganjapreneur.com/2018-farm-bill-may-fully-legalize-industrial-hemp/

https://www.wsj.com/articles/recreational-marijuana-use-in-canada-to-become-legal-soon-1529512701

https://www.fool.com/investing/2018/05/26/which-states-will-be-voting-on-marijuana-in-2018.aspx

[BottomBounce]

$MJNA has 85 employees. Medical Marijuana, Inc., an investment holding company, operates in the medical marijuana and industrial hemp markets. Its products range from patented and proprietary based cannabinoid products to seed and stalk or isolated high value extracts manufactured and formulated for the pharmaceutical, nutraceutical, and cosmeceutical industries. The company licenses its proprietary testing, genetics, labeling and packaging, tracking, production, and standardization methods for the medicinal cannabinoid industry. It engages in the research and development of cannabinoid-based pharmaceuticals; and marketing and distribution of cannabidiol hemp oil-based products. In addition, the company provides management support and services to cooperatives, collectives, health and wellness facilities, and medical clinics; and consulting and securities services to businesses and individuals in the legal cannabis industry. Further, it focuses on the treatment of pain and other medical disorders with the application of chewing gum-based cannabis/cannabinoid medical products. Medical Marijuana, Inc. was formerly known as Hemp Deposit Distribution Corp. and changed its name to Medical Marijuana, Inc. in March, 2011. Enormous Market cap at $328.701 Million. Has total cash of $2.31 Million. The company was incorporated in 2003 and is headquartered in Poway, California. Undervalued Cannabis & Hemp Pipeline: https://www.medicalmarijuanainc.com/

[BottomBounce]

$MJNA Leading Stock Website The Motley Fool Features Medical Marijuana, Inc. as the Only Potential Publicly-Traded Winner of Hemp Farming Act of 2018

https://www.bizjournals.com/sanjose/prnewswire/press_releases/California/2018/04/03/LA55081

[BottomBounce]

$MJNA Medical Marijuana, Inc. Subsidiary HempMeds(R) Brasil Hosts Cannabis Symposium for Brazilian Doctors at Offices in San Diego https://www.epicos.com/article/152282/medical-marijuana-inc-subsidiary-hempmedsr-brasil-hold-its-second-doctor-symposium

[BottomBounce]

$MJNA Medical Marijuana, Inc. Subsidiary HempMeds® Garners National Media Coverage on TMZ Entertainment News https://www.medicalmarijuanainc.com/medical-marijuana-inc-subsidiary-hempmeds-garners-national-media-coverage-tmz-entertainment-news/

[BottomBounce]

$MJNA Medical Marijuana (OTCPK:MJNA +2.1%) Q1 revenue growth of more than 190% Y/Y exceeding $10.5M.

Total gross profits for the quarter increased more than 30% to $3.3M.

Wholly-owned subsidiary Kannaway revenues increased more than 325% to $7.5M.

"In Q1 2018, we had the best revenue quarter in the history of our Company," said Medical Marijuana, Inc. CEO Dr. Stuart Titus. "We're excited that, with the help of our investors, spokespeople and customers, we've experienced tremendous growth and the company is positioned well for continued explosive expansion."

https://seekingalpha.com/news/3358981-medical-marijuana-announces-q1-largest-sales-revenue-quarter-company-history

[BottomBounce]

$MJNA has 85 employees. Medical Marijuana, Inc., an investment holding company, operates in the medical marijuana and industrial hemp markets. Its products range from patented and proprietary based cannabinoid products to seed and stalk or isolated high value extracts manufactured and formulated for the pharmaceutical, nutraceutical, and cosmeceutical industries. The company licenses its proprietary testing, genetics, labeling and packaging, tracking, production, and standardization methods for the medicinal cannabinoid industry. It engages in the research and development of cannabinoid-based pharmaceuticals; and marketing and distribution of cannabidiol hemp oil-based products. In addition, the company provides management support and services to cooperatives, collectives, health and wellness facilities, and medical clinics; and consulting and securities services to businesses and individuals in the legal cannabis industry. Further, it focuses on the treatment of pain and other medical disorders with the application of chewing gum-based cannabis/cannabinoid medical products. Medical Marijuana, Inc. was formerly known as Hemp Deposit Distribution Corp. and changed its name to Medical Marijuana, Inc. in March, 2011. Enormous Market cap at $328.701 Million. Has total cash of $2.31 Million. The company was incorporated in 2003 and is headquartered in Poway, California. Undervalued Cannabis & Hemp Pipeline: https://www.medicalmarijuanainc.com/

[BottomBounce]

$MJNA on Dateline NBC Medical Marijuana Inc.
https://globenewswire.com/news-release/2018/05/18/1508858/0/en/Kannalife-Sciences-to-be-Featured-in-Dateline-NBC-Segment-Covering-Company-s-Research-on-CBD-Like-Molecules-as-Treatments-for-HE-CTE.html

[PennyStock Alert]

$VAPE is on watch
Low float
Low OS
Marijuana Stock

[BottomBounce]

$NEPT

[BottomBounce]

$MJNA

[BottomBounce]

$HEMP Hemp Inc (OTCMKTS:HEMP) has been bullishly up more than 30% over the last five days and more than 50% the last 30 days. HEMP is seeing upward aggressive action on legislative news and also strong internal momentum. The company is planting 25 acres of industrial hemp, which would yield 100,000 pounds of CBD oil. This news stems from a partnership between HEMP and HQ Global Education. The deal is intended to connect the cannabis industry with high-quality CBD oil.

http://financeregistrar.com/hemp-inc-otcmktshemp-is-trending-up-on-cbd-oil-partnership/

[BottomBounce]

$INSY Insys Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes supportive care products. The company markets SUBSYS, a sublingual fentanyl spray for breakthrough cancer pain in opioid-tolerant adult patients; and SYNDROS, an orally administered liquid formulation of dronabinol for the treatment of chemotherapy-induced nausea and vomiting, and anorexia associated with weight loss in patients with AIDS. It is also developing Cannabidiol Oral Solution, which has completed pediatric study for the treatment of pediatric epilepsy; has completed Phase II study to treat west syndrome; and is in Phase II study for the treatment of childhood absence epilepsy, as well as Buprenorphine Sublingual Spray that has completed Phase III study to treat acute pain. In addition, the company is developing Cannabidiol Oral Solution for the treatment of prader willi; Buprenorphine/Naloxone Sublingual Spray to treat opioid dependence; and Naloxone Nasal Spray for the treatment of opioid antagonist. Insys Therapeutics, Inc. is headquartered in Chandler, Arizona.

[Alexulf]

Cannabis stock opportunity will effect the market now and in the future.

QBL to Recommence Trading on Thursday 21st June. Significant announcement to be made then.
https://hotcopper.com.au/documentembed?id=uOMxKKzFkiWRTLKhOROKAxjvTDYC6wm7wBGZsfV1ke92GA%3D%3D

Here you have the opportunity to take advantage on facts and info from QBL. Like the ”QBL on ASX” chapter, who can provide verified facts; here is also regulated on-line stockbrokers suggestion, no games info and a good sum up. Contact information to the QBL Investor service, https://www.queenslandbauxite.com/ (remember different timezones outside Australia, trade pre-start 7 AM in Sydney, local time, trade opens 10 AM)

[BottomBounce]

Medical Marijuana, Inc. (OTC: MJNA) portfolio companies Hempmeds(R), Kannaway and Kannalife(TM) Sciences have been receiving more and more coverage of its internationalized distribution of products such as Real Scientific Hemp Oil(TM). The company's CEO, Dr. Stuart Titus, was recently featured as part of a Buzzfeed article on CBD that reached a massive audience, even as the company's portfolio company, HempMeds Brasil, was in the news for sponsoring the upcoming medical marijuana-focused "A Look into the Future" International Medicinal Seminar. That announcement came just days after the news that HempMeds has partnered with Northshore Pharmacy in Bermuda to sell the company's flagship CBD oil products.

[BottomBounce]

$INSY Insys Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes supportive care products. The company markets SUBSYS, a sublingual fentanyl spray for breakthrough cancer pain in opioid-tolerant adult patients; and SYNDROS, an orally administered liquid formulation of dronabinol for the treatment of chemotherapy-induced nausea and vomiting, and anorexia associated with weight loss in patients with AIDS. It is also developing Cannabidiol Oral Solution, which has completed pediatric study for the treatment of pediatric epilepsy; has completed Phase II study to treat west syndrome; and is in Phase II study for the treatment of childhood absence epilepsy, as well as Buprenorphine Sublingual Spray that has completed Phase III study to treat acute pain. In addition, the company is developing Cannabidiol Oral Solution for the treatment of prader willi; Buprenorphine/Naloxone Sublingual Spray to treat opioid dependence; and Naloxone Nasal Spray for the treatment of opioid antagonist. Insys Therapeutics, Inc. is headquartered in Chandler, Arizona.

[BottomBounce]

$HEMP Hemp, Inc. Consultant Agreement With HQ Global Education, Inc. to Further Company's Hemp CBD Extraction Infrastructure to Capture Billion Dollar CBD Market https://globenewswire.com/news-release/2018/03/21/1443565/0/en/Hemp-Inc-Consultant-Agreement-With-HQ-Global-Education-Inc-to-Further-Company-s-Hemp-CBD-Extraction-Infrastructure-to-Capture-Billion-Dollar-CBD-Market.html

[BottomBounce]

$INSY INSYS Therapeutics and University of California (UC) San Diego Center for Medicinal Cannabis Research to Collaborate on Clinical Trial https://globenewswire.com/news-release/2018/04/26/1488081/0/en/INSYS-Therapeutics-and-University-of-California-UC-San-Diego-Center-for-Medicinal-Cannabis-Research-to-Collaborate-on-Clinical-Trial.html

[Alexulf]

Marijuana is the safest bet today.

QBL to Recommence Trading on Thursday 21st Jun

https://hotcopper.com.au/documentembed?id=uOMxKKzFkiWRTLKhOROKAxjvTDYC6wm7wBGZsfV1ke92GA%3D%3D

[edro]

Chomp ready to fly-urgent,see chart

[HNDRXX]

$VMGI. MMJ Stock. New Management. New CEO. 0004+

[BottomBounce]

$MJNA Medical Marijuana, Inc. Subsidiary Kannaway(R) Announces New Powder Protein Shake and Hemp Pet Products
https://www.nasdaq.com/press-release/medical-marijuana-inc-and-subsidiary-kannaway-announces-january-2018-as-the-largest-revenue-sales-20180206-00804

[BottomBounce]

$MJNA Medical Marijuana, Inc. (MJNA) is a development-stage company, which operates in the cannabis and industrial hemp space in America. Through its subsidiaries and investment holdings, the Company focuses on the development, sale and distribution of hemp oil that contains naturally occurring cannabinoids, including cannabidiol (CBD) and other products containing CBD-rich hemp oil (Legal Hemp). The Company's products are formulated for the pharmaceutical, nutraceutical and cosmeceutical industries, including dietary supplements, prescription-based hemp oil for sale for the treatment of illnesses and conditions, and skin care products. The Company's services include development of cannabinoid based health and wellness products, and the development of medical grade compounds. It operates through subsidiaries, including HempMedsPX, LLC, Wellness Managed Services, LLC, Red Dice Holdings, LLC, CanChew Biotechnologies, LLC, Hempwire, LLC, Kannaway, LLC, HempVap, LLC and HempMeds Brasil.

[BottomBounce]

$HEMP Hemp, Inc. Strategic Hemp Growing Partner "Veteran Village Kins Community Arizona, Inc." Receives Coverage by The Kingman Daily Miner for Veteran-Focused Cultivation Plan
https://www.apnews.com/dcd68a708c3c7a28b65a7954d57ea842

[BottomBounce]

$MJNA #hemp #cannabis

[BottomBounce]

$INSY "SYNDROS® is a cannabinoid medicine used in adults to treat:

Loss of appetite (anorexia) in people with AIDS (Acquired Immune Deficiency Syndrome) who have lost weight
Nausea and vomiting caused by anti-cancer medicine (chemotherapy) in people whose nausea and vomiting have not improved with usual anti-nausea and vomiting medicines
SYNDROS® is the first and only FDA-approved liquid dronabinol, which allows for fast absorption, flexible dosing and a potential solution for patients who may prefer a liquid medication."

https://www.insysrx.com/products/approved

[TAH86]

Listen to Senate live in 15 mins
http://www.cpac.ca/en/senate-portal/

[Fireindahole101]

$KALY$ R/M in the works now! Check out company tweet:https://twitter.com/IncKaly/status/1004082097370337284. Recently reinstated!

[Alexulf]

Extension of MMJ Voluntary Suspension until friday 1 of june or before.

https://hotcopper.com.au/documentembed?id=uOMxKKzFkiWRTLKhOROKAxjvTDYC6wu9wRaZsfV1ke92GA%3D%3D

Ok... it is what it is. The announcement say DEALS - so it`s more then one, the complexity is more understandable then. The ASX clarification is also a factor, the holdup might be partly on them as well.
It sounds to me as it is well worth waiting for though. 4 days more.

Here you have the opportunity to take advantage on facts and info from QBL.Like the ”QBL on ASX” chapter, who can provide verified facts; here is also regulated on-line stockbrokers suggestion, no games info and a good sum up. Voluntary suspension is requested regarding a significant and strategic acquisition by QBL’s subsidiary Medical Cannabis Limited until next Fridy the 1 of june or before. Contact information to the QBL Investor service, who can reply on questions.
https://www.queenslandbauxite.com/ (remember different timezones outside
Australia, trade pre-start 7 AM in Sydney, local time, trade opens 10 AM)

[StockDetective]

$VAPE is the next marijuana stock runner!!

FDA Approval: Hive Ceramics Dab Nail 2017.

Patent License: 14 Year Term License For Distribution.

http://pdfpiw.uspto.gov/.piw?PageNum=0&docid=D0752727&IDKey=1DB6C6FD79D2%0D%0A&HomeUrl=http%3A%2F%2Fpatft.uspto.gov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO1%2526Sect2%3DHITOFF%2526d%3DPALL%2526p%3D1%2526u%3D%25252Fnetahtml%25252FPTO%25252Fsrchnum.htm%2526r%3D1%2526f%3DG%2526l%3D50%2526s1%3DD752727.PN.%2526OS%3DPN%2FD752727%2526RS%3DPN%2FD752727

http://www.hiveceramics.com/authorized-shops

[Alexulf]

MCL MMJ MANAGEMENT/TEAM MEMBER HIGHLIGHTS - Asst. Prof. David (Dedi) Meiri PhD, the TECHNION, Israel. (Timeline highlights below - click on "See More")


Dr Meiri was a guest speaker at the 2017 UIC Symposium in Melbourne. Fx Medicine's Andrew Whitfield-Cooke discusses the journey of Cannabis and the work that David and his team from the TECHNION are doing in Israel. QBL:MCL is proud to have a research partnership with the TECHNION, Israel, supporting Dr. Meiri and his team with Medical Cannabis Research.
During the interview, Dr. Meiri stated that "There is no doubt that Cannabis is making a huge change...it's a very important medicine."


TIMELINE/INTERVIEW HIGHLIGHTS
00:24 Discusses the Technion's research with Cannabis and anti-cancer research, and Cannabinoid compounds..
03:58 Discusses seasonal effects on the changing of the active compounds within the cannabis plant and how that affects the potency of Cannabis extracts.
06:23 Discusses trials with children suffering severe Epilepsy, Autism, Chron's Disease.


08:40 Discusses growing conditions and climatic effects on the potency of the plant.
09:30 Discusses the fingerprints of cannabis extracts to identify different strains to match medical conditions.
11:00 Discusses GP's use of Medical cannabis when all other medications fail.
13:18 Discusses the use of Cannabis by GP's in Israel as part of their treatment arsenal to tackle disease.
14:30 Discusses introducing Cannabis earlier in the treatment paradigm for patients with severe illness.


16:00 Discusses the whirlpool of bureaucracy between government's, politicians, regulators and GP's to get Medical Cannabis into the hands of the professionals. Dr. Meiri discusses the Database project and current clinical trials.
19:08 Discusses psychiatrists use of neuro medicines and how medical cannabis can be trialled and proved for efficacy.
20:00 Discusses the Israeli's government full support for medical Cannabis research, education and training of professionals.


22:10 Discusses how the population of Israel has changed its view on the use of medicinal cannabis. Dr. Meiri's lab is the main reference centre for all Cannabis research for the Israeli Ministry of Health.
24:00 Discusses the ignorance around medicinal cannabis education in Australia and the concerns around the lack of education and good advice.
24:50 Dr. Meiri discusses how he has 100% support for his projects by the government of Israel, the Israeli medical system, the medical fraternity and pharma companies.

Deidi Me Iri FX Medicine Interview
2017 UIC Symposium.
youtube.com



Here you have the opportunity to take advantage on facts and info from QBL.Like the QBL on ASX website chapter, who can provide verified facts; here is regulated on-line stockbrokers suggestion, no games info and a good sum up. Voluntary suspension is requested regarding a significant and strategic acquisition by QBL’s subsidiary Medical Cannabis Limited until next week.Contact information to the QBL Investor service, who can reply on questions.
https://www.queenslandbauxite.com/

[BottomBounce]

$MJNA Emmy® Award-Winning Daytime Talk Show CBS' The Doctors Features Medical Marijuana, Inc. Flagship Product Real Scientific Hemp Oil™ https://www.nasdaq.com/press-release/emmy-awardwinning-daytime-talk-show-cbs-the-doctors-features-medical-marijuana-inc-flagship-produc-20180326-00579

[BottomBounce]

$MJNA Medical Marijuana, Inc., an investment holding company, operates in the medical marijuana and industrial hemp markets. Its products range from patented and proprietary based cannabinoid products to seed and stalk or isolated high value extracts manufactured and formulated for the pharmaceutical, nutraceutical, and cosmeceutical industries. The company licenses its proprietary testing, genetics, labeling and packaging, tracking, production, and standardization methods for the medicinal cannabinoid industry. It engages in the research and development of cannabinoid-based pharmaceuticals; and marketing and distribution of cannabidiol hemp oil-based products. In addition, the company provides management support and services to cooperatives, collectives, health and wellness facilities, and medical clinics; and consulting and securities services to businesses and individuals in the legal cannabis industry. Further, it focuses on the treatment of pain and other medical disorders with the application of chewing gum-based cannabis/cannabinoid medical products. Medical Marijuana, Inc. was formerly known as Hemp Deposit Distribution Corp. and changed its name to Medical Marijuana, Inc. in March, 2011. The company was incorporated in 2003 and is headquartered in Poway, California.